A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

Antibody drugs have reshaped how we treat diseases. By harnessing the immune system to destroy tumours or temper excessive inflammation in autoimmune disorders, these therapeutics have become ...

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

A new study shows how an anticancer drug triggers an “outside in” signal that gets it sucked into a cancer cell.

Consequently, the lead optimisation or molecular evolution ... the Israeli company uses a structure-based approach, where their model is trained on millions of Antibody-Antigen pairs in order ...

A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.

P-cadherins are cell adhesion proteins that are overexpressed in cancers. This study offers insights into the regulation of cell adhesion and the design of drug delivery antibodies by showing that ...

The research team, studying the efficacy of a preventive antibody-based therapy, found it successfully protects monkeys from ...

BENGALURU: When the first outbreak happened in Pune, all heads turned and started to panic. What was this new infectious ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell.